Sign In
Buy EVR
$340.09
-6.97 (-2.01%)
At Close: Jun 03, 2026
Sagimet Biosciences to Participate in the 8th Annual Evercore ISI Healthcare Conference
07:00am, Thursday, 20'th Nov 2025
SAN MATEO, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic
Vir Biotechnology to Participate in the 8th Annual Evercore Healthcare Conference
04:05pm, Wednesday, 19'th Nov 2025
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will participate in a fireside chat at the 8
Atea Pharmaceuticals to Present at the 8th Annual Evercore Healthcare Conference
07:00am, Wednesday, 19'th Nov 2025
BOSTON, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiv
Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference
08:00am, Tuesday, 18'th Nov 2025
JERUSALEM, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (Nasdaq: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptide and protein replacement therapies, today an
Bausch Health to Participate in the 8th Annual Evercore Healthcare Conference
07:00am, Tuesday, 18'th Nov 2025
LAVAL, QC / ACCESS Newswire / November 18, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that Jean-Jacques Charhon, Executive Vice President and Chief Financial Officer, wil
Evercore's Greg Melich: Incoming Walmart CEO is the 'right guy' to take company forward next 5-7 yrs
12:17pm, Friday, 14'th Nov 2025
Greg Melich, Evercore Research Analyst, joins CNBC's 'Squawk on the Street' to shares his reaction to leadership changes at Walmart.
agilon health to Participate in the 8th Annual Evercore Healthcare Conference
04:05pm, Wednesday, 12'th Nov 2025
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that its management team wil
Amazon is probably an AI winner, says Evercore's Mark Mahaney
01:36pm, Tuesday, 11'th Nov 2025
Mark Mahaney, Evercore ISI head of internet research, joins 'The Exchange' to discuss Mahaney's thoughts on the AI trade, if investors should wait for a pullback and much more.
AN2 Therapeutics to Participate in Fireside Chat at Evercore HealthCONx Conference
05:03pm, Thursday, 06'th Nov 2025
MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron c
Keith Prusek and Hugh Rabb Join Evercore as Senior Managing Directors in the Transportation Investment Banking Group
08:00am, Monday, 03'rd Nov 2025
NEW YORK--(BUSINESS WIRE)--Evercore announced today that Keith Prusek and Hugh Rabb have joined the firm as senior managing directors in its transportation investment banking group. Both will be based
Evercore Q3 Earnings Top Estimates, Revenues Cross $1B, Stock Falls
01:26pm, Thursday, 30'th Oct 2025
EVR registers record revenues of $1.05B in Q3, beating estimates. However, its shares fall despite strong segment gains.
Evercore ISI's Mark Mahaney breaks down Meta, Alphabet Q3 results
07:29am, Thursday, 30'th Oct 2025
Mark Mahaney, Evercore ISI head of internet research, joins 'Squawk Box' to discuss Meta and Alphabet's quarterly earnings results.
Evercore Inc. (EVR) Q3 2025 Earnings Call Transcript
10:31am, Wednesday, 29'th Oct 2025
Evercore Inc. ( EVR ) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Company Participants Katy Haber - MD, Head of Investor Relations & ESG John Weinberg - Chairman & CEO Timothy LaLonde - Senior
Compared to Estimates, Evercore (EVR) Q3 Earnings: A Look at Key Metrics
10:31am, Wednesday, 29'th Oct 2025
Although the revenue and EPS for Evercore (EVR) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Str
Evercore (EVR) Tops Q3 Earnings and Revenue Estimates
08:56am, Wednesday, 29'th Oct 2025
Evercore (EVR) came out with quarterly earnings of $3.48 per share, beating the Zacks Consensus Estimate of $3.01 per share. This compares to earnings of $2.04 per share a year ago.
